切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2021, Vol. 09 ›› Issue (02) : 93 -98. doi: 10.3877/cma.j.issn.2095-5820.2021.02.007

所属专题: 经典病例 文献

调查研究

浙江地区120 245例检测新型冠状病毒血清抗体阳性率分析
陈信1, 王颖蔚1, 张幸2, 王欢3, 刘军权4,()   
  1. 1. 317200 浙江台州,天台县人民医院检验科
    2. 317200 浙江台州,台州市第二人民医院
    3. 310053 浙江杭州,杭州金域医学检验所有限公司
    4. 317200 浙江台州,天台县人民医院检验科;310053 浙江杭州,杭州金域医学检验所有限公司
  • 收稿日期:2020-08-25 出版日期:2021-05-28
  • 通信作者: 刘军权
  • 基金资助:
    浙江省医药卫生科技计划项目(2020384100)

Seroprevalence of antibodies against SARS-CoV-2 in 120 245 cases from Zhejiang province

Xin Chen1, Yingwei Wang1, Xing Zhang2, Huan Wang3, Junquan Liu4,()   

  1. 1. Department of Laboratory Medicine, Tiantai County People's Hospital, Taizhou Zhejiang 317200, China
    2. Taizhou Second People's Hospital, Taizhou Zhejiang 317200, China
    3. Hangzhou KingMed Medical Laboratory Co., Ltd., Hangzhou Zhejiang 310053, China
    4. Department of Laboratory Medicine, Tiantai County People's Hospital, Taizhou Zhejiang 317200, China; Hangzhou KingMed Medical Laboratory Co., Ltd., Hangzhou Zhejiang 310053, China
  • Received:2020-08-25 Published:2021-05-28
  • Corresponding author: Junquan Liu
引用本文:

陈信, 王颖蔚, 张幸, 王欢, 刘军权. 浙江地区120 245例检测新型冠状病毒血清抗体阳性率分析[J]. 中华临床实验室管理电子杂志, 2021, 09(02): 93-98.

Xin Chen, Yingwei Wang, Xing Zhang, Huan Wang, Junquan Liu. Seroprevalence of antibodies against SARS-CoV-2 in 120 245 cases from Zhejiang province[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2021, 09(02): 93-98.

目的

了解浙江地区新型冠状病毒血清抗体阳性率概况,以期找到后续抗体监测重点。

方法

回顾性分析浙江地区120 245例新型冠状病毒血清抗体结果,依照样本来源、年龄、性别分组,探究浙江地区人群IgG血清抗体单阳性率、IgM血清抗体单阳性率和IgG与IgM血清抗体双阳性率。

结果

在浙江地区120 245例研究对象中,发热门诊、新住院及陪护人员占比最多,年龄以30~50岁为主,IgG抗体单阳性率为0.11%,IgM抗体单阳性率为0.15%,IgG、IgM抗体双阳性率为0.13%。依照样本来源分组,发热门诊新住院及陪护人员IgG、IgM血清抗体单阳性率最高,隔离点人员IgG和IgM血清抗体双阳性率最高(0.16%);依照年龄性别分组,男性组IgG单阳性率与IgG、IgM双阳率高于女性组,且差异有统计学意义;与>50岁组相比,其他各组IgG单阳性率、IgM单阳性率、IgG和IgM双阳性率均更低,且差异有统计学意义。在检出率较高的温州地区,血清抗体IgG单阳性率(0.14%),IgM单阳性率(0.15%),IgG、IgM双阳性率(0.25%)均高于全省水平,且隔离点人员的IgM单阳性率及IgG、IgM双阳性率与医疗机构工作人员相比差异有统计学意义,男性血清抗体IgG单阳性率,IgM单阳性率,IgG、IgM双阳性率均高于女性,年龄分组可看出30岁~50岁人群阳性率较全省更高。

结论

虽然浙江地区新型冠状病毒血清抗体阳性率较低,但隔离点人员和发热门诊新住院及陪护人员阳性率较高,尤其是年龄在50岁以上的人群。为避免疫情再次暴发,疫情防控工作仍需高度重视。

Objective

To understand the seroprevalence against antibodies to SARS-CoV-2 in Zhejiang, in order to find the key point of subsequent antibody monitoring.

Methods

The results of novel coronavirus serum antibodies in 120 245 cases were retrospectively analyzed. The single-positive rate of IgG serum antibody, single-positive rate of IgM serum antibody and double positive rate of IgG and IgM serum antibody in Zhejiang area were investigated according to the sample source, age, and gender.

Results

Among the 120 245 study subjects in Zhejiang area, fever clinics, new hospitalizations and accompanying persons accounted for the most. The age was mainly 30~50 years old. The single positive rate of IgG antibody was 0.11%, the single positive rate of IgM antibody was 0.15%, and the double positive rate of IgG and IgM antibody was 0.13%. Grouped according to the sample source, the single positive rate of IgG and IgM serum antibodies for newly hospitalized and accompanying persons in fever clinics was the highest, and the double positive rate of IgG and IgM serum antibodies for people in isolation points was the highest (0.16%). Grouped by age and gender, the single positive rate of IgG in the female group compared with IgG and IgM, the double positive rate was higher than that of the male group, and the difference was statistically significant. Compared with the group more than 50 years old, the other groups had lower IgG single-positive rates, IgM single-positive rates, IgG and IgM double-positive rates, and the difference was statistically significant. In Wenzhou area with high detection rate, the single positive rate of serum antibody IgG (0.14%), the single positive rate of IgM (0.15%), and the double positive rate of IgG and IgM (0.25%) were all higher than the provincial level. In addition, the IgM single-positive rate and the IgG, IgM double-positive rate of the personnel at the isolation point were statistically different from those of the medical institution staff. The male serum antibody IgG single-positive rate, IgM single-positive rate, IgG, IgM double-positive rate were all higher than those of women. The age group showed that the positive rate of people aged 30-50 is higher than that of the whole province.

Conclusion

Although the positive rate of new coronavirus seroantibodies was low in Zhejiang, the positive rate of quarantine personnel and new hospitalized and accompanying persons in fever clinics is relatively high, especially in people over 50 years old. In order to avoid another outbreak, epidemic prevention and control work still requires great attention.

图1 检出SARS-CoV-2血清抗体阳性数量随时间变化折线图
表1 12万人次检测对象一般信息
表2 浙江地区检测对象分组SARS-CoV-2血清抗体阳性率
表3 浙江地区年龄性别分组SARS-CoV-2血清抗体阳性率
表4 温州地区检测对象分组SARS-CoV-2血清抗体阳性率
表5 温州地区年龄性别分组SARS-CoV-2血清抗体阳性率
1
Zhou P, Yang X, Wang X, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579: 270-273.
2
Sharma A, Tiwari S, Deb Manas K, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies[J]. Int J Antimicrob Agents, 2020, 56: 106054.
3
Yang Y, Xiao Z, Ye K, et al. SARS-CoV-2: characteristics and current advances in research[J]. Virol J, 2020, 17: 117.
4
World Health Organization. Coronavirus disease 2019 (COVID-19) situation report—199[R]. WHO, 2020.
5
Mathuria JP, Yadav R, Rajkumar. Laboratory diagnosis of SARS-CoV-2-A review of current methods[J]. J Infect Public Health, 2020, 13: 901-905.
6
国家卫生健康委办公厅, 国家中医药管理局办公室. 国家卫生健康委办公厅关于印发新型冠状病毒肺炎防控方案(试运行第七版)的通知[EB/OL]. (2020-03-03)

URL    
7
张瑞, 李金明. 2019新型冠状病毒特异抗体检测"假阳性"原因分析及对策[J] 中华检验医学杂志, 2020, 43(5):507-510.
8
Liya G, Yuguang W, Jian L, et al. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review[J]. APMIS, 2020, 128: 423-432.
9
Moreno-Eutimio MA, Lopez-Macias C, Pastelin-Palacios R. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes[J]. Microbes Infect, 2020, 22(4-5):226-229.
10
Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2[J]. Proc Natl Acad Sci, 2020, 117(21):11727-11734.
11
Lei C, Qian K, Li T, et al. Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig[J]. Nat. Commun, 2020, 11(1): 1-5.
12
张典, 牛慧, 王晓晓, 等. 冠状病毒的病原学特征与宿主免疫功能调控的研究进展[J]. 临床肺科杂志, 2020, 25(7):1100-1104.
13
Zhang F, Gan R, Zhen Z, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals[J]. Signal Transduct Tar, 2020, 5(1): 1-11.
14
Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis[J]. J Med Virl, 2020, 92(9):1518-1524.
15
Xu X, Sun J, Nie S, et al. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China[J]. Nat Med, 2020, 26(8):1193-1195.
16
徐万洲, 李娟, 何晓云, 等. 血清2019新型冠状病毒IgM和IgG抗体联合检测在新型冠状病毒感染中的诊断价值[J]. 中华检验医学杂志, 2020, 43(3):230-233.
17
Iversen K, Bundgaard H, Hasselbalch R B, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study[J]. The Lancet Infectious Diseases, 2020, 20(12):1401-1408.
18
Sotgiu G, Barassi A, Miozzo M, et al. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital[J]. BMC Pulm Med, 2020, 20: 203.
19
Bhaskar M E, Arun S. SARS-CoV-2 infection among community health workers in india before and after use of face shields[J]. Jama, 2020, 324(13): 1348-1349.
20
Zhu S, Zong Z. Why did so few healthcare workers in China get COVID-19 infection[J]. QJM: An International Journal of Medicine, 2020, 1-2.
21
Kaur S P, Gupta V. COVID-19 Vaccine: A comprehensive status report[J] Virus Research, 2020, 288:198114.
[1] 周灿, 史博慧, 杨谨, 李军涛, 许锐, 陈元元, 魏洪亮, 刘震, 邓智平, 樊东, 刁岩, 李雄雄, 白俊文, 任予. 乳腺癌患者新型冠状病毒感染后的临床症状:基于患者自报告结局的多中心横断面调查研究[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 157-162.
[2] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[3] 李安琪, 徐祎琳, 向天新. 新型冠状病毒感染后肺纤维化病变诊治进展[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 294-298.
[4] 吴令杰, 陈瑞烈, 陈桂佳, 肖湘明, 林钟滨. 两例获得性免疫缺陷综合征合并新型冠状病毒感染者抗病毒治疗并文献复习[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 282-286.
[5] 朱名超, 朱娅, 郭飞波, 黄银娥. 新型冠状病毒感染诱导冷凝集现象对血常规参数的影响[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 244-251.
[6] 李振华, 解宝江, 易为, 李丽, 卫雅娴, 周明书, 伊诺. 82例孕产妇对新型冠状病毒肺炎疫情防控认知的心理干预及常态化疫情防控应对要点[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(03): 173-179.
[7] 戚若晨, 马帅军, 韩士超, 王国辉, 刘克普, 张小燕, 杨晓剑, 秦卫军. 肾移植术后新型冠状病毒感染单中心诊疗经验[J]. 中华移植杂志(电子版), 2023, 17(04): 232-239.
[8] 刘路浩, 苏泳鑫, 曾丽娟, 张鹏, 陈荣鑫, 徐璐, 李光辉, 方佳丽, 马俊杰, 陈正. 新型冠状病毒感染疫情期间肾移植受者免疫抑制剂服药依从性研究[J]. 中华移植杂志(电子版), 2023, 17(03): 140-145.
[9] 国家传染病医学中心, 中华医学会器官移植学分会, 中国康复医学会器官移植康复专业委员会, 中国器官移植发展基金会器官移植受者健康管理专项基金. 实体器官移植受者新型冠状病毒感染诊疗专家共识(2023年版)[J]. 中华移植杂志(电子版), 2023, 17(02): 65-81.
[10] 邵乐宁, 何腾飞, 钟丰云, 吴浩荣. 嵌顿疝合并新型冠状病毒感染高龄患者的外科诊治体会[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(03): 280-284.
[11] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[12] 李金璞, 饶向荣. 抗病毒药物和急性肾损伤[J]. 中华肾病研究电子杂志, 2023, 12(05): 287-290.
[13] 徐静媛, 谢波, 邱海波, 杨毅. 《重症医学》课程思政建设的探索与实践[J]. 中华重症医学电子杂志, 2023, 09(03): 265-268.
[14] 李雪珠, 谢剑锋, 李晓青, 夏泽燕, 鲁玲, 顾晓霞, 马绍磊, 黄英姿. 循环式筛查与五色区域分类模式在方舱医院管理中的应用[J]. 中华重症医学电子杂志, 2023, 09(03): 316-320.
[15] 田丹阳, 刘小璇, 叶珊, 马新然, 樊东升, 傅瑜. 新型冠状病毒感染疫情对神经内科住院医师规范化培训的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 499-504.
阅读次数
全文


摘要